Volibo 0.3mg acts on intestinal enzymes responsible for breaking down complex carbohydrates and disaccharides. By slowing this process, Voglibose reduces the speed at which glucose enters the bloodstream following meals.

The medicine is particularly focused on postprandial glycemic management and may be used alongside other diabetes treatments when clinically appropriate.

Brand: Volibo

Active Ingredient: Voglibose 0.3mg

Form: Oral tablet

Quantity: 15 tablets

Category: Alpha-glucosidase inhibitor

Primary Role: Post-meal glucose regulation

Use consistently according to the prescribed meal-related dosing schedule.